USA flag logo/image

An Official Website of the United States Government

CIRCULATING TUMOR CELL ENUMERATION PRODUCT

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
96068
Program Year/Program:
2010 / SBIR
Agency Tracking Number:
N43CO201000065
Solicitation Year:
N/A
Solicitation Topic Code:
NCI
Solicitation Number:
N/A
Small Business Information
EPIC SCIENCES, INC.
3565 GENERAL ATOMICS CT SAN DIEGO, CA 92121-
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2010
Title: CIRCULATING TUMOR CELL ENUMERATION PRODUCT
Agency: HHS
Contract: N43CO201000065
Award Amount: $200,000.00
 

Abstract:

'This project was funded as a Phase I contract by the NCI Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Program in response to funding announcement number 272 "Point of Care Analysis of Circulating Tumor Cells for Cancer Diagnostics, Prognosis, and Treatment."Circulating tumor cells (CTCs) are cancer cells that shed from either the primary tumor or its metastases and are circulating in the peripheral blood. While metastases are directly responsible for the majority of cancer deaths, CTCs may constitute seeds for metastases and are instrumental for the spread of the disease. Therefore the development of CTC-related applications is very important.

Principal Investigator:

David Nelson
(858) 356-6611
david@epicsciences.com
Small Business Information at Submission:

EPIC SCIENCES, INC.
3565 GENERAL ATOMICS CT SAN DIEGO, CA 92121-

EIN/Tax ID: 611577455
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No